Skip to Content

Notice

Notice of the Advisory Committee on Biotechnology and 21st Century Agriculture; Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 65678

AGENCY:

Agricultural Research Service, USDA.

ACTION:

Notice of meeting.

SUMMARY:

In accordance with the Federal Advisory Committee Act, 5 U.S.C. App. II, the United States Department of Agriculture announces a meeting of the Advisory Committee on Biotechnology and 21st Century Agriculture (AC21).

DATES:

December 4-5, 2003, 8:30 a.m. to 5 p.m. both days. Written request to make oral presentations at the meeting must be received by the contact person identified herein at least three business days before the meeting.

ADDRESSES:

Vista C Room at the Wyndham Washington Hotel, 1400 M Street, NW., Washington, DC 20005. Requests to make oral presentations at the meeting may be sent to the contact person at USDA, Office of the Deputy Secretary, 202 B Jamie L. Whitten Federal Building, 12th and Independence Avenues, SW., Washington, DC 20250.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Michael Schechtman, Designated Federal Official, Office of the Deputy Secretary, USDA, 202B Jamie L. Whitten Federal Building, 12th and Independence Avenue, SW., Washington, DC 20250; Telephone (202) 720-3817; Fax (202) 690-4265; E-mail mschechtman@ars.usda.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The third meeting of the AC21 has been scheduled for December 4-5, 2003. The AC21 consists of 18 members representing the biotechnology industry, the seed industry, international plant genetics research, farmers, food manufacturers, commodity processors and shippers, environmental and consumer groups, along with academic researchers including a bioethicist. In addition, representatives from the Departments of Commerce, Health and Human Services, and State, and the Environmental Protection Agency, the Council on Environmental Quality, and the Office of the United States Trade Representative serve as “ex officio” members. The Committee meeting will be held from 8:30 a.m. to 5 p.m. on each day. Items on the AC21's agenda include: Continuing work to develop a report examining the impacts of agricultural biotechnology on American agriculture and USDA over the next 5 to 10 years in two sub-areas, namely (1) discussion of issues and concerns related to impacts of plant biotechnology products that may be developed over the next 5 to 10 years, as identified by AC21 work groups, and (2) preliminary presentations and introductory discussions related to animal biotechnology products that may be developed over the same time frame; and preliminary presentations and introductory discussions on the issue of the proliferation of traceability and mandatory labeling regimes for biotechnology-derived products in other countries, the implications of those regimes, and what industry is doing to attempt to address those requirements for products shipped to those countries.

Background information regarding the work of the AC21 will be available on the USDA Web site at http://www.usda.gov/​agencies/​biotech/​ac21.html. On December 4, 2003, if time permits, reasonable provision will be made for oral presentations of no more than five minutes each in duration.

The meeting will be open to the public, but space is limited. If you would like to attend the meetings, you must register by contacting Ms. Dianne Harmon at (202) 720-4074, by fax at (202) 720-3191 or by E-mail at dharmon@ars.usda.gov at least 5 days prior to the meeting. Please provide your name, title, business affiliation, address, telephone, and fax number when you register. If you require a sign language interpreter or other special accommodation due to disability, please indicate those needs at the time of registration.

Start Signature

Edward B. Knipling,

Acting Administrator, ARS.

End Signature End Supplemental Information

[FR Doc. 03-29230 Filed 11-20-03; 8:45 am]

BILLING CODE 3410-03-P